Navigation Links
Hair Loss Research Study Reveals Important Breakthrough in the Treatment of Male Pattern Baldness

Hair loss research study shows the benefits of a novel combination of two FDA Approved topical medications. This triple blind controlled hair loss prevention study highlights a remarkable new finding.

Pleasant Valley, New York (Vocus) June 1, 2010 -- Dr. Oscar Klein M.D. today announced the results of a triple blind hair loss research study involving two FDA approved hair growth medications: Minoxidil and Finesteride.

Three groups of individuals were used in the study: Group I was the placebo group, Group II applied 5% Minoxidil lotion, Group III applied 5% Minoxidil lotion, 0.025% tretinoin (Retin A) and 0.1% Finesteride. The subjects were evaluated every six months with the help of a subjective questionnaire, objective examination and close-up photographs.

In the Placebo Group, there was neither any improvement nor deterioration. In the Minoxidil Group 25% of the subjects showed hair growth. In the Combination Group as much as 75% of the subjects showed improvement. The quality of the newly grown hair was also better in the combination group.

According to Dr. Klein, “The significance of this study cannot be over emphasized." This study serves as the basis for Dr. Klein's development of ProMox™ - one of the most exciting hair loss products available for men.

Dr Klein is known for creating unique and innovative hair growth treatments for men and women by combining real world client results with ongoing product research and development. Dr Klein offers ongoing consultations for his clients. He listens closely to their hair growth product experiences and monitors their progress.

This study may have focused on male pattern baldness, but it has implications for hair loss in women. Dr Klein created a product called ReMox™ which is a combination of 5% Monoxidil and 0.025% tretinoin (Retin A). Dr. Klein's exclusive, easily absorbed ReMox™ formula gives far superior results than competing topical remedies for up to HALF the cost.

Dr Klein is committed to helping his clients achieve their desired hair growth results and offers a no cost, private, confidential consultation in order to create an individualized treatment program.

Visit: for all the details on this study or to find out more about the benefits of Dr. Klein’s hair growth products for men and women and to schedule your free no-obligation in-person or phone consultation with Dr. Klein. US callers call: 1 800 992-2474, International callers call 1 845 723-4334.

About Dr. Oscar Klein, MD:

Dr. Oscar Klein M.D. holds degrees in medicine and psychiatry. Dr. Klein worked as a consulting psychiatrist in Tel Aviv and New York and served as an emergency physician at Putnam Community and Vassar Hospitals. Dr. Klein established the Westbay Medical Center in Florida and was the sole primary physician on staff. He established his own psychiatric practice and is credited for the Center’s management of psychopharmacology. He is also founder of a comprehensive site that educates men and women on hair re-growth, offers information and lists information on Dr. Klein’s breakthrough hair growth promoting products for men and women. Dr. Klein consults with clients across the country and overseas from his offices in Pleasant Valley, New York. Dr. Klein has treated tens of thousands of clients around the world who are walking testimonies to the results of his products.    


Dr Klein MD
59 Traver Road
Pleasant Valley, NY 12569
1 845 723-4334 phone
1 845 723-4339 fax

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. U of A discovery offers promising research for spinal-cord injury treatments
2. Research finds surgery outperforms drug therapy in treatment of benign prostatic hyperplasia
3. Researchers report no difference in breast cancer characteristics after oophorectomy
4. Vanderbilt researchers play major role in new center on electronic health information privacy
5. New research at the University of Leicester links shoplifting to your personality
6. OHSU joins forces with UO, Harvard to accelerate Fanconi anemia research
7. Pitt researchers discover gene mutation linked to lymphatic dysfunction
8. Researchers validate a new test for assessing childrens and teenagers fitness to prevent morbidity
9. Chef Charles Phillips of Nashville's 1808 Grille, Teams up with National Foundation for Cancer Research, Offering Gourmet Healthy Living Options
10. Rensselaer researcher wins $1.4 million NIH grant to enable faster cancer treatment planning
11. NIH awards $10M to Einstein for diabetes research
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology: